In ST-elevation myocardial infarction patients, every single minute is essential for the prognosis. Reperfusion therapy is the primary goal. Dissolution or removal of the intracoronary thrombus provides the best chance for mortality reduction. It can be achieved by pharmacological (fibrinolysis) or mechanical-catheter-based (primary percutaneous coronary intervention) approaches within 12 h. Optimal adjunctive medical therapy includes aspirin, nitrates, P2Y12 inhibitors, anticoagulants, beta-blockers, angiotensin converting enzyme inhibitors, and statins. Secondary prevention strategies are necessary to prevent hospital readmissions, new cardiovascular events, and premature death.
Ricci, B., Manfrini, O., Cenko, E., Bugiardini, R. (2018). STEMI: Management. Oxford : Oxford: Elsevier [10.1016/B978-0-12-809657-4.99744-8].
STEMI: Management
Ricci, B.;Manfrini, O;Cenko, E.;Bugiardini, R.
2018
Abstract
In ST-elevation myocardial infarction patients, every single minute is essential for the prognosis. Reperfusion therapy is the primary goal. Dissolution or removal of the intracoronary thrombus provides the best chance for mortality reduction. It can be achieved by pharmacological (fibrinolysis) or mechanical-catheter-based (primary percutaneous coronary intervention) approaches within 12 h. Optimal adjunctive medical therapy includes aspirin, nitrates, P2Y12 inhibitors, anticoagulants, beta-blockers, angiotensin converting enzyme inhibitors, and statins. Secondary prevention strategies are necessary to prevent hospital readmissions, new cardiovascular events, and premature death.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
